Saturday 17 October 2026
Export NSYS’s income statement to Excel — free account
Nortech Systems Incorporated
NSYS Healthcare Medical Devices
In the quarter to June 2026, revenue grew 9.34%, EPS fell 8.33%, free cash flow fell 1,567.2% and total debt fell 79.0%, each against the same quarter a year earlier.
10.32
0.19
−1.81%
Follow NSYS
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 1.69 | 3.13 | 2.77 | 2.65 | 2.52 | 5.45 | 9.31 | 7.45 | 9.13 | 6.50 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 5.52 | 6.24 | 8.08 | 7.46 | 10.14 | 14.20 | 19.56 | 16.52 | 19.15 | 12.40 | |||||
| People | |||||||||||||||
| People | Employees | 904 | 800 | 819 | 784 | 699 | 807 | 832 | 775 | 744 | 713 | ||||
| Revenue/emp, $m | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | 0.14 | 0.16 | 0.18 | 0.17 | 0.17 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 117 | 112 | 113 | 116 | 104 | 115 | 134 | 139 | 128 | 118 | ||||
| Gross margin, % | 11.87 | 10.79 | 11.74 | 10.81 | 9.28 | 13.77 | 15.27 | 16.58 | 13.05 | 15.21 | |||||
| EBT | 0 | (2) | 0 | (1) | (1) | 8 | 3 | 5 | (1) | 0 | |||||
| EBT margin, % | 0.07 | (1.84) | 0.43 | (0.70) | (1.19) | 6.96 | 2.59 | 3.92 | (0.73) | 0.01 | |||||
| Net income | 0 | (2) | 0 | (1) | (2) | 7 | 2 | 7 | (1) | 0 | |||||
| Depreciation | 2 | 3 | 2 | 2 | 5 | 2 | 2 | 2 | 2 | 1 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 42.45 | 40.91 | 42.11 | 43.65 | 39.17 | 43.22 | 49.95 | 51.19 | 46.51 | 42.62 | ||||
| Earnings | 0.02 | (0.89) | 0.06 | (0.46) | (0.58) | 2.68 | 0.75 | 2.53 | (0.47) | (0.09) | |||||
| Cash flow | 1.29 | 0.29 | 0.91 | 0.37 | 0.51 | (1.70) | 2.01 | 0.65 | (0.82) | 0.99 | |||||
| Capex | (0.71) | (0.09) | (0.52) | (0.28) | 2.07 | (0.27) | (0.90) | (0.47) | (0.46) | (0.06) | |||||
| Free cash flow | 0.58 | 0.20 | 0.39 | 0.09 | 2.58 | (1.98) | 1.11 | 0.18 | (1.28) | 0.93 | |||||
| Book value | 8.12 | 7.22 | 7.83 | 7.50 | 7.04 | 9.80 | 10.46 | 12.98 | 12.34 | 12.44 | |||||
| Shares, m | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 377.00 | 0.00 | 50.71 | 0.00 | 0.00 | 3.86 | 15.83 | 4.04 | 0.00 | 0.00 | ||||
| P/S | 0.09 | 0.10 | 0.08 | 0.11 | 0.18 | 0.24 | 0.24 | 0.20 | 0.22 | 0.17 | |||||
| P/B | 0.47 | 0.55 | 0.46 | 0.66 | 1.03 | 1.07 | 1.15 | 0.79 | 0.84 | 0.60 | |||||
| EV/Sales | 0.20 | 0.22 | 0.20 | 0.24 | 0.26 | 0.32 | 0.29 | 0.24 | 0.29 | 0.18 | |||||
| EV/FCF | 15.09 | 45.74 | 22.04 | 115.46 | 3.94 | (7.00) | 12.95 | 83.58 | (10.50) | 8.40 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 4 | 1 | 2 | 1 | 1 | (5) | 5 | 2 | (2) | 3 | ||||
| Capex | (2) | 0 | (1) | (1) | 6 | (1) | (2) | (1) | (1) | 0 | |||||
| Free cash flow | 2 | 1 | 1 | 0 | 7 | (5) | 3 | 0 | (4) | 3 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 19 | 20 | 21 | 21 | 22 | 29 | 28 | 32 | 34 | 26 | ||||
| Total debt | 14 | 15 | 15 | 15 | 12 | 10 | 7 | 6 | 9 | 1 | |||||
| Net debt | 14 | 14 | 14 | 15 | 8 | 8 | 5 | 4 | 8 | (1) | |||||
| Shareholders’ equity | 22 | 20 | 21 | 20 | 19 | 26 | 28 | 35 | 34 | 35 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 0.08 | (4.55) | 0.30 | (2.02) | (2.60) | 11.47 | 2.94 | 9.50 | (1.76) | (0.35) | ||||
| ROIC | 1.11 | (2.32) | 2.25 | 0.41 | (1.44) | 4.21 | 7.36 | 9.37 | (0.29) | 1.82 | |||||
| ROE | 0.20 | (11.75) | 0.82 | (6.05) | (8.10) | 32.28 | 7.49 | 21.85 | (3.76) | (0.74) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Nortech Systems Incorporated vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| NNOX Nano-X Imaging Ltd. | $38.6M | — (loss-making) | — (loss-making) | +36.71% (above 0%: growing) | n/m | −21.37% (below 0%: shrinking) | (1,050.87%) | (1,334.91%) | Compare |
| CVRX CVRx, Inc. | $37.0M | — (loss-making) | — (loss-making) | +15.57% (above 0%: growing) | n/m | −11.18% (below 0%: shrinking) | 87.39% | (82.92%) | Compare |
| ELUT Elutia Inc. | $34.9M | 0.6× | — (loss-making) | −11.65% (below 0%: shrinking) | n/m | −2.52% (below 0%: shrinking) | 59.62% | (327.85%) | Compare |
| QTI QT Imaging Holdings, Inc. | $34.8M | — (loss-making) | — (loss-making) | +103.20% (above 0%: growing) | n/m | −236.31% (below 0%: shrinking) | 41.16% | (25.07%) | Compare |
| NSYS Nortech Systems Incorporated | $29.5M | 27.9× | 17.5× | +9.34% (above 0%: growing) | −8.33% (below 0%: shrinking) | −1,567.16% (below 0%: shrinking) | 17.00% | 1.86% | |
| ITOC iTonic Holdings Ltd. | $29.3M | — | — | — | — | — | — | — | Compare |
| PMI Flag Ship Acquisition Corp | $23.4M | 0.5× | — (loss-making) | +38.62% (above 0%: growing) | n/m | +46.79% (above 0%: growing) | 20.85% | (156.70%) | Compare |
| NSPR InspireMD, Inc. | $22.3M | — (loss-making) | — (loss-making) | −0.39% (below 0%: shrinking) | n/m | −26.00% (below 0%: shrinking) | (43.70%) | (815.64%) | Compare |
| ARAY Accuray Incorporated | $20.8M | — (loss-making) | — (loss-making) | −20.87% (below 0%: shrinking) | n/m | +117.83% (above 0%: growing) | 35.22% | 5.47% | Compare |
| Median of peers | $32.1M | — | — | +15.57% | — | −11.18% | 35.22% | (156.70%) |
Nortech Systems Incorporated (NSYS) key facts
- Nortech Systems Incorporated (NSYS) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- As of October 15, 2026, NSYS traded at $10.32, a market capitalization of $29.5 million.
- Return on equity was −0.74% and debt-to-equity 0.07.
- Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 2.79 (grey zone) for fiscal 2025.